The overview of the therapeutic strategy for motor complications of Parkinson's disease
Currently, levodopa remains to be the most effective agent to improve motor symptoms in Parkinson's disease (PD). However, the chronic use is associated with the emergence of motor fluctuations, which has been one of the most troublesome dilemmas in PD's treatment. A plenty of clinical stu...
Main Authors: | Ying WAN, Zhen-guo LIU |
---|---|
Format: | Article |
Language: | English |
Published: |
Tianjin Huanhu Hospital
2013-08-01
|
Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
Subjects: | |
Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/778 |
Similar Items
-
The potential mechanisms for motor complications of Parkinson's disease
by: Nian XIONG, et al.
Published: (2013-08-01) -
Quantifying upper limb motor impairment in people with Parkinson’s disease: a physiological profiling approach
by: Lewis A. Ingram, et al.
Published: (2021-02-01) -
Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
by: Kye Won Park, et al.
Published: (2020-09-01) -
From medications to surgery: advances in the treatment of motor complications in Parkinson’s disease
by: Kanae Jennifer Nagao, et al.
Published: (2019-08-01) -
Pay attention to the early diagnosis of Parkinson's disease and prevention of its motor complications
by: Sheng-di CHEN, et al.
Published: (2013-07-01)